You're viewing a free preview.You're viewing a free preview — a sample of each dataset.

Funding Tracker

Every disclosed longevity science round — size, stage and the investors behind it.

233 funding rounds tracked

Company	Amount	Round	Investors	Date
Sava	$36M	Series B	Ascensia Diabetes Care, Balderton Capital, Norrsken VC, Simplyhealth Ventures, JamJar Investments, Pentland Ventures	10/09/26
Sensible Biotechnologies	$47M	Series A	Oxford Science Enterprises, OTB Ventures, In-Q-Tel, Recode Ventures, Isomer Capital, Y Combinator, BlueYard Capital, Backed VC, Kaya VC, Civilization Ventures	10/06/26
Tiny Health	$33M	Series B	B Capital, Spero Ventures, The Venture City, Overwater Ventures, Black Opal Ventures, Denver Ventures, Pave Health Ventures, Alumni Ventures, Gaingels, Pari Passu Ventures	09/29/26
Renewal Bio	Undisclosed	Private Placement	Immortal Dragons	09/28/26
Basecamp Research	$140M	Series C	S32, NVIDIA, Menlo Ventures (Anthology Fund), Anthropic, Catalio Capital Management, European Tech Collective, Firebrand River Capital, Inception Fund, King Philanthropies, NATO Innovation Fund, PostScriptum, Redalpine, The Rockefeller Foundation, Singular, Sovereign AI, True Ventures	09/23/26
AstronauTx	Undisclosed	Grant	The Michael J. Fox Foundation for Parkinson's Research, Parkinson's UK	09/22/26
HexemBio	$15.5M	Private Placement	Happiness Capital, Draper Associates, Boost VC	09/15/26
Magnitude Biosciences	£1.3M	Private Placement	Northstar Ventures, Maven Capital Partners, angel investors	09/15/26
Vincere Biosciences	$2.7M	Grant	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK/NIH)	09/10/26
Inspiren	$70M	Series C	NewView Capital, Insight Partners, Primary Venture Partners, Scale Venture Partners, Vintage Investment Partners, Lightbank, Avenir Growth Capital, Story Ventures, Camber Creek	09/09/26

Showing 10 of 233 funding rounds

7-day free trial · already have an account?

Peek at other modules

News Feed

Daily longevity science headlines — aging research, deals, trials, and policy — with AI summaries.

Companies

The longevity science company universe by segment, stage, geography and capital raised.

Clinical Trials

Longevity science and aging research trials by phase, sponsor, status and indication.

People & Movers

Who is joining, leaving and founding across longevity science and aging research.

Research

Peer-reviewed aging research distilled into investor-relevant takeaways.

Regulatory

FDA, EMA and policy developments that move aging research and the longevity market.